ARCHIVES

Study Confirms Cancer Risk Increase Due To Combined HRT

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

Obit: John Ultmann, A Leader In Clinical Oncology.

October 27, 2000

Duke Vice Dean Cuffe Promises Complete, Independent Probe Of Work By Potti, Nevins.

July 30, 2010

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

New Trial For Metastatic Colorectal Cancer Testing Vaccine-Chemotherapy Combination

March 29, 2002

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000